Nevertheless, in established serine synthesis-deficient tumor xenografts, acute silencing of SLC6A14/SLC12A4 and to a lesser degree SLC6A14/SLC25A15 reduced tumor growth and serine levels, despite a large proportion of DOX escapers. Here, SLC25A15 is linked to neoplasm.